Licensed vaccine
IXCHIQ
FDA-licensed vaccine · Valneva Austria GmbH · STN 125777
Key facts
| Trade name | IXCHIQ |
|---|---|
| Proper name | Chikungunya Vaccine, Live |
| Manufacturer | Valneva Austria GmbH |
| Submission tracking number (STN) | 125777 |
| FDA product areas | Biologics |
| Recent FDA documents | December 8, 2023 Summary Basis for Regulatory Action - IXCHIQ, Demographic Subgroup Information – Chikungunya Vaccine, Live (IXCHIQ), Approval History, Letters, Reviews, and Related Documents - IXCHIQ, November 9, 2023 Approval Letter - IXCHIQ, Package Insert - IXCHIQ |
| FDA page updated | Jan 10, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: